Global /South Korea /Healthcare /Diagnostics & Research /246250

SLS BIO Co., Ltd.

246250

• KRX: 246250 • Delayed

1,969KRW 4.5%

1.28 USD

As of 5 June 2026, SLS BIO Co., Ltd. has a market cap of $17.49M USD, ranking #38042 globally and #2421 in South Korea. It ranks #3393 in the Healthcare sector, and #9 in the Diagnostics & Research industry.

Global Rank

38042

Country Rank

2421

Sector Rank

3393

Industry Rank

Key Stats

Market Cap

$17.49MUSD

26.89B KRW

Enterprise Value

$13.58MUSD

20.82B KRW

Revenue (TTM)

$2.59MUSD

3.98B KRW

EBITDA (TTM)

-$1.84MUSD

-2.82B KRW

Net Income (TTM)

-$3.19MUSD

-4.9B KRW

EBITDA Margin

-71%

Profit Margin

-123%

PS Ratio

6.7

PB Ratio

3.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Lee Young Tae open_in_new

Founded

2007

Website

slabs.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
4.5%	4.6%	21%	19%	7.7%	2.3%	-16%	-51%	-62%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	246250 (주)에스엘에스 ISIN: KR7246250005 Shares Out.: Shares Outstanding: 15.048M¹ Shares Float: 14.829M² TV: TradingView: KRX: 246250 SA: Stock Analysis: KRX: 246250 YF: Yahoo Finance: 246250.KS GF: Google Finance: KRX: 246250 BA: Barron's: 246250 MS: Morningstar: XKRX: 246250	1,969 KRW	TV: TradingView: KRX: 246250 SA: Stock Analysis: KRX: 246250 YF: Yahoo Finance: 246250.KS GF: Google Finance: KRX: 246250 BA: Barron's: 246250 MS: Morningstar: XKRX: 246250

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About SLS BIO Co., Ltd.

SLS BIO Co., Ltd develops diagnostic technologies in South Korea. It offers pharmaceuticals quality control testing services, including pharmaceutical equivalence study, raw materials/finished drugs test, and other analysis testing services; and efficacy evaluation services, such as immune function-based efficacy evaluation and pharmacokinetics and toxicokinetics analysis services. In addition, it provides diagnostic kits comprising rapid allergy test, rapid bovine pregnancy diagnosis, and horse individual forensic kits, as well as nano-bio technologies. The company was formerly known as Specialty Lab Solution Co., Ltd. and changed its name to SLS BIO Co., Ltd in July 2017. The company was founded in 2007 and is based in Suwon-si, South Korea.

Similar Companies

Industry: Diagnostics & Research (South Korea)

Name	Market Cap (USD) diff.	PE	Country
DHX Company Co., Ltd. KRX: 031860	$8.56M 13.15B KRW -51%	-	South Korea

Industry: Diagnostics & Research (Global)

Name	Market Cap (USD) diff.	PE	Country
Quest Diagnostics Inc. NYSE: DGX	$20.96B 120K%	20.9	United States
Exact Sciences Corp. NASDAQ: EXAS	$20.03B 114K%	-	United States
Q Qiagen N.V. FRA: QIA	$8.5B 7.3B EUR 49K%	20.2	Netherlands
Chrome Holding Co. OTCMKTS: MEHCQ	$96.4M 451%	-	United States
Global Cord Blood Corp. OTCMKTS: CORBF	$73.65M 321%	0.8	Hong Kong
DNA Chip Research Inc. TSE: 2397	$46.18M 7.39B JPY 164%	-	Japan

chevron_leftBack